# Study of the Efficacy and Safety of Longidaze® for the Treatment of Patients With External Genital Endometriosis

> **NCT04962620** · — · UNKNOWN · sponsor: **NPO Petrovax** · enrollment: 149 (estimated)

## Conditions studied

- External Genital Endometriosis

## Interventions

- **DRUG:** Bovhyaluronidase azoximer

## Key facts

- **NCT ID:** NCT04962620
- **Lead sponsor:** NPO Petrovax
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-26
- **Primary completion:** 2021-05-14
- **Final completion:** 2021-08-01
- **Target enrollment:** 149 (ESTIMATED)
- **Last updated:** 2021-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04962620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04962620, "Study of the Efficacy and Safety of Longidaze® for the Treatment of Patients With External Genital Endometriosis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04962620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*